Vanguard Investments Australia »

Taysha Gene Therapies shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-06-30 $244k 36k 6.81
2026-03-31 $160k 36k 4.47